[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356527-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356527-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","enhancing-5-fluorouracil-efficacy-in-colorectal-cancer-by-inhibiting-glutathione-antioxidant-mechanisms-with-an-xct-inhibitor","Enhancing 5-fluorouracil efficacy in colorectal cancer by inhibiting glutathione antioxidant mechanisms with an xCT inhibitor","","Colorectal cancer remains a major cause of cancer-related mortality, driven in part by chemotherapy resistance. This study tests small-molecule inhibitors targeting glutathione metabolism to determine whether glutathione blockade can strengthen 5-fluorouracil (5-FU) activity. In HCT-116 cells, IKE reduces cystine uptake and elevates ROS, and its combination with 5-FU decreases cell viability. In an in ovo tumor model, IKE plus 5-FU reduces tumor growth, while single agents show limited effects. Targeting xCT-mediated cystine uptake may improve chemotherapy response through oxidative-stress mechanisms.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/enhancing-5-fluorouracil-efficacy-in-colorectal-cancer-by-inhibiting-glutathione-antioxidant-mechanisms-with-an-xct-inhibitor/356527/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/enhancing-5-fluorouracil-efficacy-in-colorectal-cancer-by-inhibiting-glutathione-antioxidant-mechanisms-with-an-xct-inhibitor/356527.png","ImageObject",300,407,{"name":42,"@type":43},"Rhys","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why focus on glutathione inhibition to improve 5-fluorouracil efficacy?","Question",{"text":63,"@type":64},"Cancer cells counteract 5-FU–induced cytotoxic ROS by upregulating antioxidant systems, particularly glutathione (GSH) and related redox pathways. Inhibiting glutathione-related mechanisms is expected to shift the redox balance toward oxidative damage and improve chemotherapy effectiveness.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which inhibitors were tested in HCT-116 cells and what were their effects?",{"text":68,"@type":64},"Three small-molecule inhibitors targeting glutathione metabolism were tested: CB-839 (glutaminase inhibitor), IKE (xCT transporter inhibitor), and Polydatin (glucose-6-phosphate dehydrogenase inhibitor). CB-839 decreased viability, Polydatin had no effect, and IKE reduced cystine uptake and increased ROS; none caused marked cell death when used alone.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the IKE and 5-FU combination perform in vitro and in vivo?",{"text":72,"@type":64},"IKE combined with 5-FU increases ROS and reduces viability in combination conditions. In an in ovo model, the IKE plus 5-FU regimen reduces tumor growth, while each agent alone produces limited effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356527,1790823598,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEnhancing 5-fluorouracil efficacy in colorectal cancer by inhibiting glutathione antioxidant mechanisms with an xCT inhibitor  \nSenanur Malcanlı1, Remzi OkanAkar2,3, Engin Ulukaya2,3, Ali Burak Özkaya4 &Öykü GönülGeyik5􀀍  \nColorectal cancer is a leading cause of cancer-related mortality, and chemotherapy resistance remains a major challenge. We investigated whether inhibiting glutathione could enhance the efficacy of 5-fluorouracil (5-FU) in colorectal cancer. Three small-molecule inhibitors targeting glutathione metabolism were tested in HCT-116 cells: CB-839 (glutaminase inhibitor), IKE (xCT transporter inhibitor), and Polydatin (glucose-6-phosphate dehydrogenase inhibitor). Their effects on glutathione levels, ROS accumulation, and cell viability were first evaluated. CB-839 decreased cell viability, Polydatin had no effect, and IKE reduced cystine uptake and increased ROS, although none of the inhibitors alone induced marked cell death. We next examined whether they could enhance 5-FU activity. Although CB-839 and Polydatin did not improve 5-FU efficacy, IKE increased ROS levels and reduced viability when combined with 5-FU. In an in ovo model, the combination of IKE and 5-FU reduced tumor growth, whereas each agent alone had a limited effect. These findings suggest that targeting xCT-mediated cystine uptake may enhance chemotherapy response and could be a promising approach for treating colorectal cancer.  \nKeywords Colorectal cancer, 5-fluorouracil, Glutathione inhibition, Oxidative stress, xCT transporter, Chemotherapy resistance  \nColorectal cancer (CRC) is the third most common cancer globally and the second leading cause of cancerrelated deaths, arising from the malignant transformation of benign polyps in the colon or rectum1–3. Various therapeutic approaches have been used for cancer treatment, but they often come with side effects that reduce their efficacy4,5. To minimize these effects and combat drug resistance, research is focused on targeted therapies. Combining targeted molecules with low-dose chemotherapy can minimize side effects and enhance treatment efficacy6.  \n5-FU is the most widely used chemotherapeutic drug for the treatment ofCRC7. 5-FU selectively kills cancer cells by increasing reactive oxygen species (ROS) to cytotoxic levels. To increase reactive oxygen species at a cytotoxic level8,9. However, cancer cells counteract ROS-induced damage by upregulating antioxidant systems, including glutathione (GSH) and NADPH, which protect against oxidative stress10. High GSH levels have been linked to tumor progression and drug resistance, making the modulation of the redox balance in cancer cells a potential therapeutic approach11–13.  \nGlutathione, which plays a role in ROS neutralization, is a tripeptide composed of the amino acids cysteine, glutamate, and glycine12. Glutathione synthesis in cancer cells is largely dependent on cysteine, a precursor derived from cysteine, which is transported into the cell via the xCT (SLC7A11) transporter14. Overexpression of xCT, associated with poor prognosis, enhances GSH production and contributes to therapeutic resistance15, 16. As such, xCT has emerged as a promising target for anticancer therapies, with inhibitors like imidazole ketone erastin (IKE) showing potency in selectively depleting GSH and inducing apoptosis through ROS accumulation16–19.  \n1Institute of Graduate Education, Department of Cancer Biology And Pharmacology, Istinye University, Istanbul, Turkey. 2Faculty of Medicine, Department of Medical Biochemistry, Istinye University, Istanbul, Turkey. 3Molecular Cancer Research Center (ISUMKAM), Istinye University, Istanbul, Turkey. 4Faculty of Medicine, Department of Medical Biochemistry, Izmir University of Economics, Izmir, Turkey. 5Faculty of Medicine, Department of Medical Biology, Istinye University, Istanbul, Turkey. 􀀍 email: [oyku.geyik@istinye.edu.tr](oyku.geyik@istiny","cbCaibF8WSnSJFzT","https://ap.wps.com/l/cbCaibF8WSnSJFzT","pdf",1980050,11,"English","# Keywords\n# Colorectal cancer and chemotherapy resistance\n# 5-FU and redox (ROS/GSH) mechanisms\n# Glutathione biosynthesis and xCT (SLC7A11)\n# Targeting antioxidant defenses with GLS and G6PDH\n# Material and method\n## Cell culture\n## Cell viability","[{\"question\":\"Why focus on glutathione inhibition to improve 5-fluorouracil efficacy?\",\"answer\":\"Cancer cells counteract 5-FU–induced cytotoxic ROS by upregulating antioxidant systems, particularly glutathione (GSH) and related redox pathways. Inhibiting glutathione-related mechanisms is expected to shift the redox balance toward oxidative damage and improve chemotherapy effectiveness.\"},{\"question\":\"Which inhibitors were tested in HCT-116 cells and what were their effects?\",\"answer\":\"Three small-molecule inhibitors targeting glutathione metabolism were tested: CB-839 (glutaminase inhibitor), IKE (xCT transporter inhibitor), and Polydatin (glucose-6-phosphate dehydrogenase inhibitor). CB-839 decreased viability, Polydatin had no effect, and IKE reduced cystine uptake and increased ROS; none caused marked cell death when used alone.\"},{\"question\":\"How does the IKE and 5-FU combination perform in vitro and in vivo?\",\"answer\":\"IKE combined with 5-FU increases ROS and reduces viability in combination conditions. In an in ovo model, the IKE plus 5-FU regimen reduces tumor growth, while each agent alone produces limited effects.\"}]","Enhancing 5-fluorouracil efficacy in colorectal cancer by inhibiting glutathione antioxidant mechanisms with an xCT inhibitor | PDF",1790125838,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdedbfaa33c888f5a76bb46280b85907.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c695b69b640a75058016f2f30bf78919.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66db06761a21d2d04c717c014f62dff0.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3dce8a3c2f740784e42f1e9e471474c.webp",980,1287]